Personalized immunosuppression for kidney transplant patients
Individualized Immunosuppression for Kidney Transplant Recipients
This study is working on a special tool to help find the best medication plan for people who have received a kidney transplant, aiming to reduce side effects and improve their overall health.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11015002 on NIH RePORTER |
What this research studies
This research aims to develop a personalized tool to determine the best immunosuppression regimen for kidney transplant recipients. By analyzing individual risk factors, the goal is to minimize the side effects associated with immunosuppression, such as infections and cardiovascular diseases, which significantly impact patient health. The approach involves a combination of clinical data and patient-centered evidence to tailor treatment plans specifically for each recipient. This individualized strategy seeks to improve long-term health outcomes for kidney transplant patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have received a kidney transplant and require ongoing immunosuppression therapy.
Not a fit: Patients who have not undergone kidney transplantation or those who are not on immunosuppression therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective immunosuppression strategies, enhancing the longevity and quality of life for kidney transplant recipients.
How similar studies have performed: Previous research has indicated the importance of individualized treatment approaches in transplant medicine, suggesting that this personalized strategy could yield significant improvements in patient outcomes.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Bae, Sunjae — New York University School of Medicine
- Study coordinator: Bae, Sunjae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.